89 results on '"Witjes, Alfred J."'
Search Results
2. Lymphotropic Nanoparticle-enhanced MRI in Prostate Cancer: Value and Therapeutic Potential
3. COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES: PD12-12
4. Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial
5. BLADDER CANCER IN 2015: Improving indication, technique and outcome of radical cystectomy
6. Fluorescence cystoscopy: the end of biopsies for carcinoma in situ detection?
7. The prognostic value of family history among patients with urinary bladder cancer
8. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis
9. EXPERT CONSENSUS DOCUMENT: Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
10. Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer
11. Defining and Treating the Spectrum of Intermediate Risk Nonmuscle Invasive Bladder Cancer
12. Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy
13. Radical Cystectomy in a Dutch University Hospital: Long-Term Outcomes and Prognostic Factors in a Homogeneous Surgery-Only Series
14. Defining Progression in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard Definition
15. Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer
16. Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer
17. Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS)
18. Individualized image-based lymph node irradiation for prostate cancer
19. BLADDER CANCER: Elderly and female patients fare the worst and deserve better
20. Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer
21. Microvascularity in transition zone prostate tumors resembles normal prostatic tissue
22. The Clinical Epidemiology of Urachal Carcinoma: Results of a Large, Population Based Study
23. Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy
24. LONG-TERM CLINICAL BENEFIT OF HEXAMINOLEVULINATE ENABLED FLUORESCENCE CYSTOSCOPY: 1668
25. CURRENT PRACTICE GAPS IN THE USE OF BCG MAINTENANCE: RESULTS OF THE INTERNATIONAL PATIENT DATA SURVEY: 533
26. Antitumor Effects of cis-Urocanic Acid on Experimental Urothelial Cell Carcinoma of the Bladder
27. A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group
28. Reduction of Treatment Volume and Radiation Doses to Surrounding Tissues With Intraprostatic Gold Markers in Prostate Cancer Radiotherapy
29. Pharmacokinetics and toxicity of intravesical TMX-101: a preclinical study in pigs
30. Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues
31. Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction
32. Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients
33. Effect of distraction on the performance of endourological tasks: a randomized controlled trial
34. Contemporary management of low-risk bladder cancer
35. Quantitative Analysis of Lymph Vessel Characteristics in Organ Confined Prostate Cancer†
36. European Association of Urology Guidelines on Primary Urethral Carcinoma—2020 Update
37. Developments in intravesical therapy for non-muscle-invasive bladder cancer
38. Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer
39. The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy
40. Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific Antigen
41. Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy
42. Predictive Value of PCA3 in Urinary Sediments in Determining Clinico-Pathological Characteristics of Prostate Cancer
43. Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin
44. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy
45. Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer
46. Molecular markers for detection, surveillance and prognostication of bladder cancer
47. Computerized Whole Slide Quantification Shows Increased Microvascular Density in pT2 Prostate Cancer as Compared to Normal Prostate Tissue
48. Detailed Analysis of Histopathological Parameters in Radical Prostatectomy Specimens and PCA3 UrineTest Results
49. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils
50. A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.